News
AgNovos Healthcare Completes Enrollment for CONFIRM Clinical Study
AgNovos Healthcare is pleased to announce the completion of enrollment for its CONFIRM clinical study.
News & Events
Keep up to date on AgNovos events and related news
Featured posts
All Articles
ESCEO – AGNOVOS YOUNG INVESTIGATOR AWARD Reception
AgNovos and ESCEO support young investigators at the “BREAKFAST EVENT” on Saturday April 06, 2019 from 08.00 - 09.00
AgNovos Healthcare at WCO in Paris from April 4th - 7th, 2019
AgNovos Healthcare will participate in WCO in Paris from April 4th - 7th, 2019 exhibiting the CE-marked OSSURE LOEP kit and host the ESCEO – AGNOVOS YOUNG INVESTIGATOR AWARD “BREAKFAST EVENT”
AgNovos Healthcare and ESCEO support YOUNG INVESTIGATORS at WCO in Paris
AgNovos Healthcare is proud to partner again with ESCEO to provide grants to young investigators at the WCO in Paris.
New Pre-Clinical Data on OSSURE LOEP published in Journal of Orthopedic Research
Current pharmaceutical therapies can reduce hip fractures by up to 50%, but compliance to treatment is low and therapies take up to 18 months to reduce risk. Thus, alternative or complementary approaches to reduce the risk of hip fracture are needed.
AgNovos Healthcare will Participate in the Osteologie Kongress in Frankfurt from March 28th - 30th, 2019 presenting scientific lectures
AgNovos Healthcare will participate in the Osteologie Kongress in Frankfurt from March 28th - 30th .
LOEP® included in 2019 IOF and ESCEO European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Osteoporosis International recently published diagnosis and management guidance from ESCEO and IOF for postmenopausal women with osteoporosis. The publication marks the first time that Local Osteo-Enhancement Procedure has been recognized in this global treatment guidance document.